New World Medical

What New World Medical does

New World Medical, Inc. is a privately held ophthalmic medical device company headquartered in Rancho Cucamonga, California, founded by Dr. A. Mateen Ahmed in the late 1980s after his exposure to onchocerciasis (river blindness) patients in Nigeria. The company designs, manufactures, and globally distributes a focused portfolio of surgical glaucoma devices, including the Ahmed Glaucoma Valve (the world's only glaucoma drainage device with a built-in valve system), the Ahmed ClearPath non-valved drainage device, the KDB GLIDE excisional goniotomy device, the STREAMLINE Surgical System (an implant-free platform featuring proprietary ClickPulse Technology), the VIA360 Surgical System (a viscoelastic delivery catheter with ActiveInject Technology), and biocompatible human allograft tissue for tube shunt surgery. Its technology base centers on mechanical instrumentation for both conventional and unconventional aqueous outflow pathways, with multiple FDA 510(k) clearances and an extensive clinical evidence base including over 100 peer-reviewed publications for KDB GLIDE.

The company operates a hybrid go-to-market model combining a dedicated US direct surgical sales force with an exclusive international distribution network covering more than 78 countries across North America, LATAM, Europe, South and Southeast Asia, Africa, the Middle East, and Oceania. Products are sold on a per-procedure consumable basis to ophthalmic surgeons, glaucoma specialists, hospitals, and ambulatory eye care centers, with pricing not publicly disclosed and procured through direct sales relationships or the company's online ordering portal. Marketing is concentrated on clinical education and surgeon training via the LEARN platform, surgical videos, webinars, and conferences such as ASCRS, rather than direct-to-consumer channels.

Beyond commercial sales, New World Medical funds the Sidra Tree Foundation with 10% of annual profits to democratize global eye care access, and partners with humanitarian NGOs including HCP Cureblindness, Orbis International, Cure Blindness Project, Cure Glaucoma Foundation, ACE Global, AGS Cares, and Liga International for mission-based product donations. The company is founder-controlled, employs 101–250 people, and is led by CEO Bilal Khan, President/COO Khalid Mansour, and CCO Raymond Kong, with Dr. Malik Y. Kahook serving as Chief Medical Advisor.

Name

New World Medical

Legal name

New World Medical, Inc.

Website

https://newworldmedical.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

101–250 employees

Short description

New World Medical is a privately held ophthalmic medical device company that designs, manufactures, and globally distributes surgical glaucoma devices—including valved and non-valved drainage devices, goniotomy instruments, and viscoelastic delivery systems—serving ophthalmic surgeons, hospitals, and eye care centers in 78+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty) (HLAHAJAI)

akta.pro secondary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Ophthalmic surgical devices
• Glaucoma drainage devices
• Minimally invasive glaucoma surgery
• Goniotomy surgical instruments
• Viscoelastic delivery systems

Headquarters

HQ city

Rancho Cucamonga

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure, Others

Revenue model

1. Medical Device Sales: Sale of ophthalmic surgical devices including glaucoma drainage devices (Ahmed Glaucoma Valve, Ahmed ClearPath), goniotomy devices (KDB GLIDE), surgical systems (STREAMLINE, VIA360), and human allograft tissue products for ophthalmic surgery.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

New World Medical designs, manufactures, and sells proprietary ophthalmic surgical devices used by glaucoma surgeons to lower intraocular pressure and preserve vision. Its portfolio includes valved and non-valved glaucoma drainage devices (Ahmed Glaucoma Valve, Ahmed ClearPath), excisional goniotomy instruments (KDB GLIDE), implant-free surgical systems combining goniotomy with viscoelastic delivery (STREAMLINE, VIA360), and human allograft tissue products used in tube shunt surgery. Devices are sold directly to hospitals and eye care centers in the US and through exclusive distributors in 78+ countries.

Product overview

New World Medical offers a comprehensive suite of surgical glaucoma devices designed to preserve and enhance vision. The portfolio centers on the Ahmed Glaucoma Valve (the world's only valved glaucoma drainage device), complemented by the Ahmed ClearPath non-valved drainage device, KDB GLIDE excisional goniotomy device, STREAMLINE Surgical System with ClickPulse Technology, and VIA360 Surgical System for viscoelastic delivery. Human allograft tissue products support tube shunt surgery. All devices are designed, manufactured, and marketed globally with a focus on surgical glaucoma interventions.

Differentiator

Problem solved

Functional benefit

Brands

• Sidra Tree Foundation: A foundation established by New World Medical to strategically focus charitable efforts towards democratizing global eye care. The company dedicates 10% of its profits each year to fund this foundation.

Products and services

• Ahmed Glaucoma Valve The world's only glaucoma drainage device featuring a built-in valve system, designed for immediate IOP reduction with single-quadrant implantation. Offers lowest complication rates among glaucoma drainage devices based on more than 30 years of clinical use; intended for ophthalmic surgeons managing refractory or complex glaucoma.
• Ahmed ClearPath Non-valved glaucoma drainage device with a flexible plate that conforms to the curvature of the eye, available in two plate sizes (250mm² and 350mm²) with anterior fixation eyelets for easier suturing. Used by ophthalmic surgeons in tube shunt procedures for patients requiring non-valved GDDs.
• Ahmed ClearPath ST Next-generation non-valved glaucoma drainage device with smaller tube lumen, anterior fixation eyelets, and globe-conforming flexible material. Available in 250mm² and 350mm² plate sizes; intended for ophthalmic surgeons performing tube shunt surgery.
• KDB GLIDE Excisional goniotomy device with a proprietary ramp and dual blades for precise trabecular meshwork tissue excision. FDA cleared for IOP reduction in adult patients with primary open-angle glaucoma during cataract surgery or as a standalone procedure; supported by 100+ published studies including Level-I RCT and 5-year data.
• STREAMLINE Surgical System First-line, implant-free surgical system featuring proprietary ClickPulse Technology that creates precision goniotomies and delivers controlled amounts of ophthalmic viscosurgical device (OVD) into the canal of Schlemm in one unified step, allowing up to 8 applications per procedure. Enhanced 2025 version adds a transparent tip for improved visualization of key anatomical structures.
• VIA360 Surgical System Viscoelastic delivery system with proprietary ActiveInject Technology enabling on-demand viscoelastic delivery independent of catheter movement, with a rotatable cannula supporting up to 360-degree catheterization via a single entry. Includes a Smart Prime System optimizing viscoelastic volume efficiency; intended for ophthalmic surgeons performing canaloplasty and trabeculotomy procedures.
• Human Allograft Tissue

Quantifiable outcome

• KDB GLIDE reduces IOP by ≥20% on average with over 100 published studies including Level-I RCT data and 5-year data
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Sidra Tree FoundationcoreOthersNew World Medical dedicates 10% of profits each year to fund the Sidra Tree Foundation, which aims to democratize global eye care. The foundation is established to strategically focus charitable efforts.
• Liga International - Flying Doctors of MercyminorStrategic or Co-development PartnerHumanitarian organization that coordinates medical mission trips to underserved regions. New World Medical employees participate in sponsored mission trips through this organization.
• HCP CureblindnessminorStrategic or Co-development PartnerMultinational eye care NGO supporting global efforts to deliver high-quality surgical products to those who need them most.
• Orbis InternationalminorStrategic or Co-development PartnerInternational non-profit organization dedicated to saving sight worldwide, partnering for eye care delivery in developing countries.
• Cure Blindness ProjectminorStrategic or Co-development PartnerNonprofit organization focused on eliminating preventable blindness globally through surgical interventions.
• Cure Glaucoma FoundationminorStrategic or Co-development PartnerFoundation supporting glaucoma treatment and awareness initiatives.
• ACE GlobalminorStrategic or Co-development PartnerGlobal organization supporting eye care access and humanitarian medical missions.
• AGS CaresminorStrategic or Co-development PartnerCharitable program supporting access to glaucoma care for underserved populations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Carl Zeiss Meditec: German ophthalmic medtech leader offering surgical microscopes, IOLs, and consumables used in glaucoma and cataract surgery. Competes with NWM in the ophthalmic OR and offers complementary products.
• Alcon: Global ophthalmic medtech leader with surgical glaucoma offerings (Hydrus Microstent acquired via Ivantis) plus a broad surgical/portfolio. Competes with NWM in MIGS but also in cataract and broader ophthalmic OR supplies.
• AbbVie (Allergan Aesthetics / Eye Care): Through Allergan acquisition, has Durysta (bimatoprost implant) and other glaucoma therapies. Competes with NWM in the glaucoma treatment paradigm but primarily on pharmaceutical side.
• Bausch + Lomb: Major ophthalmic medtech company offering surgical devices, IOLs, and pharmaceuticals including the Streamline series of instruments. Broad portfolio competes with NWM in glaucoma surgical suites globally.
• Johnson & Johnson Vision: Part of J&J MedTech, offers ophthalmic surgical devices including the iTrack microcatheter for canaloplasty and broader cataract/vitreoretinal portfolio. Overlaps with NWM in MIGS and viscoelastic delivery procedures.

Emerging players

• iSTAR Medical: Belgium-based MIGS company developing MINIject, a suprachoroidal drainage device. Competes with NWM's Ahmed drainage devices in next-generation surgical glaucoma but is earlier stage.
• MicroSurgical Technology: Smaller US-based manufacturer of ophthalmic surgical instruments, including some glaucoma tools. Comparable scale and surgical-focused product portfolio to NWM.

Direct peers

• Glaukos Corporation: Public US medtech company focused exclusively on MIGS and interventional glaucoma, with products like iStent inject W competing directly with NWM's KDB GLIDE and STREAMLINE. Most direct head-to-head competitor in surgical glaucoma.
• Sight Sciences: Public US MIGS company with the OMNI Surgical System for viscoelastic delivery and trabeculotomy, directly overlapping with NWM's VIA360 and KDB GLIDE in angle-based glaucoma surgery. Closest peer in MIGS technology profile.

Regional players

• Santen Pharmaceutical: Japanese ophthalmology company with significant presence in Asia-Pacific, focused on pharmaceuticals and surgical devices for glaucoma. Comparable therapeutic focus but regional and primarily pharmaceutical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nwm_inc
• YouTubeyoutube.com/channel/UCgdX-lPG9Sf1_dhDjeBxKCQ
• Facebookfacebook.com/NewWorldMedical
• LinkedInlinkedin.com/company/new-world-medical
• Instagraminstagram.com/newworldmedical/?hl=en

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New World Medical